Novel neutralization mechanism of a human antibody with pan-coronavirus reactivity
Xiaoyu Sun(Shanxi Agricultural University), Bing Sun(China Three Gorges University), Hongzhou Lu(Fudan University), Gaowei Hu(Shanghai Medical College of Fudan University), Longfei Ding(Shanghai Public Health Clinical Center), Weihui Fu, Zhiyang Ling(Center for Excellence in Molecular Cell Science), Chen Zhao(Oslo University Hospital), Shuai Xia(Shanghai Medical College of Fudan University), Yuanfei Zhu(Shanghai Medical College of Fudan University), Shuangfeng Chen(Chinese Academy of Sciences), Renhong Yan(Southern University of Science and Technology), Aidong Qu(Shanghai FRP Research Institute (China)), Shujuan Du(Shanghai Medical College of Fudan University), Xu Zhou(Heidelberg University), Chenli Qiu, Xiaoyan Zhang(Fujian Medical University), Lu Lu(Shanghai Medical College of Fudan University), Youhua Xie(Shanghai Medical College of Fudan University), Qiang Zhou(Anhui Medical University), Xiuling Li(Dalian Institute of Chemical Physics), Chenjian Gu(Washington University in St. Louis), Yaguang Zhang(Sichuan University), Zhuo Yang(Scripps Research Institute), Mu Liu(Shanghai Medical College of Fudan University), Yonghui He, Songhua Yuan(Shanghai Medical College of Fudan University), Xiao Lu, Chunyan Yi(Institute of Plant Protection), Liyan Ma(Chinese Academy of Sciences), Jianqing Xu(Weifang Medical University), Wangpeng Gu(Center for Excellence in Molecular Cell Science), Qiang Deng(Kunming University of Science and Technology)
Cited by 1
Related Papers
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
|Cellular and Molecular Immunology|2020|759
Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
|New England Journal of Medicine|2013|655
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
|RePEc: Research Papers in Economics|0|647